iShares
IWFS.L
IE00BP3QZD73
iShares MSCI World Mid-Cap Equal Weight UCITS ETF
Loading chart...

Risk & Diversification Scores

Transparent evaluation of price volatility (SRI) and 4-dimensional portfolio diversification.

Volatility Risk Score
5/7 Elevated
5 / 7 SRI PRIIPs Risk Class

Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon).

Volatility (5Y)
13.0% p.a.
5-Year Horizon
Max Drawdown (5Y)
-17.3%
Deepest Drawdown
Sharpe Ratio
0.29
Moderate (0.0 - 0.5)
Rec. Holding Period
5 - 10+ Years
Investment Horizon
Elevated Risk / Growth: Score Basis:
Diversification Score
Broadly Diversified (< 35%)
88 / 100 Portfolio Diversification
4 Dimensions: Holdings (30%) • Sectors (25%) • Industries (25%) • Regions (20%)

High risk diversification: No dependency on individual heavyweights.

Top 10 Holdings
2.2%
Low Concentration
Effective Holdings
~737
of 741 holdings
Top Sector
20.4%
Industrials
Top Region / Country
38.0%
United States
Excellent multi-dimensional diversification across holdings, industries, and geographies.

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Stable Long-Term Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +9.6%
3 Years 11.4% -14.4% 0.9 +12.7%
5 Years 13.0% -17.3% 0.29 +6.3%
10 Years 14.3% -29.9% 0.33 +7.2%

Notes & Warnings

🟢 Favorable / fair valuation: Avg P/E of 18.2
🟢 Excellent global diversification (Score 88/100)
🟢 Balanced position distribution (< 35% in Top 10)
🟢 Deep market liquidity & capital coverage (Tier 1)
Solid fund volume
🟡 Moderate analyst coverage (13.2 analysts)
⚠️ Elevated Interest Rate Sensitivity: 37% in rate-sensitive or leverage-heavy industries (real estate, banks, utilities).
⚠️ Elevated Regulatory & Policy Risk: 43% in heavily regulated industries (defense, regulated utilities, healthcare policy).
🟢 Strong Long-Term Stability: The asset exhibits consistently low volatility across 5 and 10 years (<16% p.a.).
ende